During the consultation on the draft guidance Janssen, the manufacturer of the drug, submitted further information for the committee to consider.
This included a revised patient access scheme which involves providing the drug to the NHS at a discounted price, further information on which patients would benefit most and clarification on how many patients could receive the drug.
These factors enabled the committee to revise its preliminary recommendation and now recommend the drug for use on the NHS.
More top news
The Chancellor will promise to fix a glitch, which means repayments continue to be taken for up to 12 months after the loan is paid off.
The proposal will see the introduction of a discounted railcard for 26-30-year-olds, as the government looks to lessen the cost of living.
The vessel went missing last week with 44 sailors on board.